181 related articles for article (PubMed ID: 1997469)
1. Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.
Bosse A; Ueda Y; Wuisman P; Jones DB; Vollmer E; Roessner A
J Cancer Res Clin Oncol; 1991; 117(1):43-9. PubMed ID: 1997469
[TBL] [Abstract][Full Text] [Related]
2. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
Park YK; Yang MH; Park HR
Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
[TBL] [Abstract][Full Text] [Related]
3. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
4. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma.
Salas S; de Pinieux G; Gomez-Brouchet A; Larrousserie F; Leroy X; Aubert S; Decouvelaere AV; Giorgi R; Fernandez C; Bouvier C
Virchows Arch; 2009 Jan; 454(1):81-7. PubMed ID: 19050913
[TBL] [Abstract][Full Text] [Related]
5. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
6. The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach.
Bosse A; Vollmer E; Böcker W; Roessner A; Wuisman P; Jones D; Fisher LW
Pathol Res Pract; 1990 Oct; 186(5):651-7. PubMed ID: 2287591
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
Chiba H; Matsuyama T
Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
[TBL] [Abstract][Full Text] [Related]
8. De-differentiated chondrosarcoma is not a 'de-differentiated' chondrosarcoma.
Aigner T; Dertinger S; Neureiter D; Kirchner T
Histopathology; 1998 Jul; 33(1):11-9. PubMed ID: 9726043
[TBL] [Abstract][Full Text] [Related]
9. Periosteal osteosarcoma and parosteal chondrosarcoma evaluated by double immunohistochemical staining. Report of 2 cases.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H
Acta Orthop Scand; 1994 Jun; 65(3):355-8. PubMed ID: 7518993
[TBL] [Abstract][Full Text] [Related]
10. Morphological typing of chondrosarcoma: a study of 94 cases.
Welkerling H; Dreyer T; Delling G
Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):419-25. PubMed ID: 2035255
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
[TBL] [Abstract][Full Text] [Related]
12. [Pathomorphology of malignant chondrogenic bone tumors--an analysis of 94 cases from the Hamburg Bone Tumor Register (1974-1989)].
Delling G; Welkerling H
Z Orthop Ihre Grenzgeb; 1992; 130(1):1-8. PubMed ID: 1532267
[TBL] [Abstract][Full Text] [Related]
13. ERG expression in chondrogenic bone and soft tissue tumours.
Shon W; Folpe AL; Fritchie KJ
J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
[TBL] [Abstract][Full Text] [Related]
14. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of osteonectin in various types of osteosarcoma.
Schulz A; Jundt G; Berghäuser KH; Gehron-Robey P; Termine JD
Am J Pathol; 1988 Aug; 132(2):233-8. PubMed ID: 3165250
[TBL] [Abstract][Full Text] [Related]
16. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
17. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
[No Abstract] [Full Text] [Related]
18. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
Fanburg-Smith JC; Bratthauer GL; Miettinen M
Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
[TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]